CEACAM5 and neoplasm: Serum tumor markers were elevated in 110 patients before surgery; 36.4% and 16.4% of patients had abnormal elevation of carbohydrate antigen 19–9 (CA19-9) and carcinoembryonic antigen (CEA), respectively (Table 2).